miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations-Reference-Cited by-同舟云学术

miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations

Published:2019-10 Issue: Volume:47 Page:101436
ISSN:0890-8508
Container-title:Molecular and Cellular Probes
language:en
Short-container-title:Molecular and Cellular Probes

Author:

Li Yan,Mao Min,Liu Hong,Wang Xiaomin,Kou Zhen,Nie Yuling,Wang Yichun,Wang Zengsheng,Huang Qin,Lang Tao,Gu Zailinuer,An Li,Zhang Xiaoyan,Fu Lin

Funder

National Natural Science Foundation of China

Natural Science Foundation of Xinjiang Uygur Autonomous Region

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference65 articles.

1. Geography, ethnicity and "roots" in chronic lymphocytic leukemia;Ruchlemer;Leuk. Lymphoma,2013

2. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia;Berndt;Nat. Commun.,2016

3. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia;Berndt;Nat. Genet.,2013

4. Familial predisposition and genetic risk factors for lymphoma;Cerhan;Blood,2015

5. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia;Di Bernardo;Nat. Genet.,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation;Cancers;2023-05-08

2. miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance– An emphasis on the interaction of signaling pathways;Pathology - Research and Practice;2023-03

3. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia;Biomarkers in Medicine;2021-06

4. The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment;Diagnostics;2021-05-10

5. Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia;Biomarker Research;2020-09-07